EGFR and non-small cell lung carcinoma: In this report, the follow-up data and clinical outcomes, focused on the EGFR mutant cohort of the JME study, are presented, and the impact of preT790M in patients with surgically resected EGFR-mutated NSCLC on RFS and OS is elucidated.